Effect of GaAlAs 940 Laser on Pain and Wound Healing After Free Gingival Graft
Biomodulatory Effects of GaAlAs 940 nm on Pain Control and Wound Healing at Palatal Donor Site Following Free Gingival Graft Harvesting: a Randomized Controlled Clinical Trial
1 other identifier
interventional
36
1 country
1
Brief Summary
This randomized controlled clinical trial aims to evaluate the biomodulatory effects of a 940-nm GaAlAs diode laser on postoperative pain control and wound healing at the palatal donor site following free gingival graft harvesting. Adult patients undergoing free gingival graft surgery will be randomly allocated to receive either a single session of adjunctive diode laser irradiation immediately after surgery or conventional postoperative care alone. Postoperative pain will be assessed using a visual analog scale, while clinical parameters related to wound healing, including bleeding tendency, epithelialization, and wound size reduction, will be evaluated at predefined follow-up time points. The findings of this study may contribute to the clinical understanding of photobiomodulation in free gingival graft surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedFirst Submitted
Initial submission to the registry
December 27, 2025
CompletedFirst Posted
Study publicly available on registry
December 30, 2025
CompletedDecember 30, 2025
December 1, 2025
1 year
December 27, 2025
December 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Postoperative pain
Zero is equivalent to no pain and 10 indicates the worst possible pain.
2 hours, 3 days, and 7 days after surgery
Post-surgical analgesic consumption
The number of 500-mg acetaminophen tablets consumed by participants during the first 3 days after surgery.
Within 3 days after surgery
Epithelialization of the palatal donor site
Epithelialization at the palatal donor site assessed as a binary outcome (yes/no) using a hydrogen peroxide bubbling test, classified as non-epithelialized (presence of bubbles) or completely epithelialized (absence of bubbles).
Day 7 and 14 after surgery
Remaining wound area
Changes in palatal donor site wound area measured using serial intraoral digital scans obtained at predefined follow-up time points
Immediately after surgery, and 3, 7, and 14 days after surgery
Study Arms (2)
Laser group
EXPERIMENTALAfter suturing was completed at the recipient site, the donor site in the laser group was irradiated according to the manufacturer's recommended settings. Laser application was performed in the "Pain Therapy" mode using an Epic X diode laser (940 nm wavelength; 0.1 W power; energy density 4 J/cm²; continuous mode; exposure time 40 s; total energy 12 J). The laser beam was held perpendicular to the donor-site wound surface at 0.5 cm, with a spot size of 1 cm². Following irradiation, a palatal stent was placed.
Control group
ACTIVE COMPARATORAfter suturing was completed at the recipient site. In the control group, only the palatal stent was applied without laser irradiation.
Interventions
A single session of 940-nm GaAlAs diode laser irradiation is applied to the palatal donor site immediately after free gingival graft harvesting using a continuous, non-contact mode (0.1 W, 4 J/cm² for 40 seconds), in combination with the use of a palatal stent.
In the control group, only the palatal stent was applied without laser irradiation after suturing was completed at the recipient site
Eligibility Criteria
You may qualify if:
- ≥18 years of age;
- systemically healthy individuals without any conditions that could affect wound healing (e.g., diabetes, immunosuppression, coagulation disorders, Candida infection;
- full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) \<15%;
- no previous history of palatal tissue harvesting;
- no use of overdentures or partial dentures covering the donor area.
You may not qualify if:
- pregnant or breastfeeding women;
- smokers;
- patients with psychiatric disorders; and
- patients taking any medications that impair tissue healing and affect pain perception.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City
Ho Chi Minh City, Vietnam
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Periodontal surgeries are performed by a periodontist with more than 20 years of clinical experience, who is not involved in laser irradiation or clinical outcome assessment. Laser irradiation and digital scanning of the palatal wound area are performed by a trained investigator who does not participate in clinical outcome evaluation. Clinical assessments and measurements of scanned images are conducted by an independent periodontist who is blinded to group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident Physician, Department of Periodontics, University of Dentistry, HCMC
Study Record Dates
First Submitted
December 27, 2025
First Posted
December 30, 2025
Study Start
October 1, 2024
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
December 30, 2025
Record last verified: 2025-12